<!DOCTYPE html>
<html lang="" xml:lang="">
  <head>
    <title>Cancer in Liver and Intrahepatic Bile Ducts</title>
    <meta charset="utf-8" />
    <meta name="author" content="Carolina Santos, Filipe Santos e Hugo Anjos" />
    <link href="libs/remark-css/default.css" rel="stylesheet" />
    <script src="libs/kePrint/kePrint.js"></script>
    <link rel="stylesheet" href="my_theme.css" type="text/css" />
  </head>
  <body>
    <textarea id="source">




class: title-slide

&lt;img src="fcullogo.png" alt="drawing" width="250"/&gt;

# Liver and Intrahepatic Bile Ducts Cancer
## Mortality in European Countries 
### **Carolina Santos**, **Filipe Santos** &amp; **Hugo Anjos** 
#### University of Lisbon, Faculty of Sciences
##### Laboratory of Biostatistics 2019/2020

---
class: intro-slide

# Introduction 

## Objective:

* Explore **Liver and Intrahepatic Bile Ducts Cancer mortality, geographical and time trends**

## Selected Countries:

* **Austria**, **Cyprus**, **Germany**, **Malta**, **Portugal** and **European Union**


.center[
&lt;img src="bileductcancer.png" border="3" alt="drawing" width="400" height="250" /&gt; 
]

### Image from: [medindia.net](https://www.medindia.net/patients/patientinfo/bile-duct-cancer.htm)

---
class: third-slide, center, middle

## Time trends in the mortality rates between countries for all age groups combined



&lt;img src="ninja-presentation_files/figure-html/q1 females&amp;males-1.png" style="display: block; margin: auto;" /&gt;

Overall **increasing trend** for every country &amp; values for **mortality for males** are **higher than** those of **females**

---
class: fourth-slide, center, middle

## Mortality rates by age groups between countries in 2016



&lt;img src="ninja-presentation_files/figure-html/q2 females-1.png" style="display: block; margin: auto;" /&gt;

The **first age groups** show very **low mortality** rate &amp; **older population** is **more susceptible** to die due to this kind of cancer 

---
class: fifth-slide, center, middle
## Mortality rates by age groups between countries in 2016

&lt;img src="ninja-presentation_files/figure-html/q2 males-1.png" style="display: block; margin: auto;" /&gt;

Mortality rate is **higher for the Male population** &amp; **older population** is **more susceptible** to die due to this kind of cancer

---
class: sixth-slide, middle

.center[
## Changes in percentage terms between 2011 and 2016
] 




&lt;table class="table table-striped" style="margin-left: auto; margin-right: auto;"&gt;
 &lt;thead&gt;
  &lt;tr&gt;
   &lt;th style="text-align:center;background-color: Linen !important;"&gt; Country &lt;/th&gt;
   &lt;th style="text-align:center;background-color: Linen !important;"&gt; Females &lt;/th&gt;
   &lt;th style="text-align:center;background-color: Linen !important;"&gt; Males &lt;/th&gt;
  &lt;/tr&gt;
 &lt;/thead&gt;
&lt;tbody&gt;
  &lt;tr&gt;
   &lt;td style="text-align:center;background-color: white !important;"&gt; Austria &lt;/td&gt;
   &lt;td style="text-align:center;background-color: white !important;"&gt; -22.0% &lt;/td&gt;
   &lt;td style="text-align:center;background-color: white !important;"&gt; 7.8% &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:center;background-color: Linen !important;font-style: italic;"&gt; Cyprus &lt;/td&gt;
   &lt;td style="text-align:center;background-color: Linen !important;font-style: italic;"&gt; 29.9% &lt;/td&gt;
   &lt;td style="text-align:center;background-color: Linen !important;font-style: italic;"&gt; 19.8% &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:center;background-color: white !important;"&gt; European Union &lt;/td&gt;
   &lt;td style="text-align:center;background-color: white !important;"&gt; 4.0% &lt;/td&gt;
   &lt;td style="text-align:center;background-color: white !important;"&gt; 8.4% &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:center;background-color: Linen !important;"&gt; Germany &lt;/td&gt;
   &lt;td style="text-align:center;background-color: Linen !important;"&gt; 1.8% &lt;/td&gt;
   &lt;td style="text-align:center;background-color: Linen !important;"&gt; 4.5% &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:center;background-color: white !important;font-style: italic;"&gt; Malta &lt;/td&gt;
   &lt;td style="text-align:center;background-color: white !important;font-style: italic;"&gt; 24.0% &lt;/td&gt;
   &lt;td style="text-align:center;background-color: white !important;font-style: italic;"&gt; 71.5% &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:center;background-color: Linen !important;"&gt; Portugal &lt;/td&gt;
   &lt;td style="text-align:center;background-color: Linen !important;"&gt; 15.6% &lt;/td&gt;
   &lt;td style="text-align:center;background-color: Linen !important;"&gt; 25.7% &lt;/td&gt;
  &lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;

                        
* *Female Population*: the country that changed the most was **Cyprus** with an **increase of 29.9%**

* *Male Population*: the country that changed the most was **Malta** with an **increase of 71.5%**

---
class: seventh-slide, center, middle

## Changes in percentage terms between 2011 and 2016 

&lt;img src="ninja-presentation_files/figure-html/ex3-1.png" style="display: block; margin: auto;" /&gt;

* Even though Cyprus and Malta show the biggest increase between 2011 and 2016, that's not the case for the other years
---
class: eighth-slide, middle

.center[
## Most common cancers for Females in 2011 and 2016
]







&lt;table class="table table-striped" style="margin-left: auto; margin-right: auto;"&gt;
 &lt;thead&gt;
&lt;tr&gt;
&lt;th style="border-bottom:hidden; padding-bottom:0; padding-left:3px;padding-right:3px;text-align: center; padding-right: 4px; padding-left: 4px; background-color: white !important;" colspan="2"&gt;&lt;div style="border-bottom: 1px solid #ddd; padding-bottom: 5px; "&gt;2011&lt;/div&gt;&lt;/th&gt;
&lt;th style="border-bottom:hidden; padding-bottom:0; padding-left:3px;padding-right:3px;text-align: center; padding-right: 4px; padding-left: 4px; background-color: white !important;" colspan="2"&gt;&lt;div style="border-bottom: 1px solid #ddd; padding-bottom: 5px; "&gt;2016&lt;/div&gt;&lt;/th&gt;
&lt;/tr&gt;
  &lt;tr&gt;
   &lt;th style="text-align:center;background-color: Linen !important;"&gt; CancerSite &lt;/th&gt;
   &lt;th style="text-align:center;background-color: Linen !important;"&gt; Deaths &lt;/th&gt;
   &lt;th style="text-align:center;background-color: Linen !important;"&gt; Deaths &lt;/th&gt;
   &lt;th style="text-align:center;background-color: Linen !important;"&gt; CancerSite &lt;/th&gt;
  &lt;/tr&gt;
 &lt;/thead&gt;
&lt;tbody&gt;
  &lt;tr&gt;
   &lt;td style="text-align:center;background-color: white !important;"&gt; Breast &lt;/td&gt;
   &lt;td style="text-align:center;background-color: white !important;"&gt; 112822 &lt;/td&gt;
   &lt;td style="text-align:center;background-color: white !important;"&gt; 117976 &lt;/td&gt;
   &lt;td style="text-align:center;background-color: white !important;"&gt; Breast &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:center;background-color: Linen !important;"&gt; Trachea, Bronchus and Lung &lt;/td&gt;
   &lt;td style="text-align:center;background-color: Linen !important;"&gt; 96192 &lt;/td&gt;
   &lt;td style="text-align:center;background-color: Linen !important;"&gt; 109590 &lt;/td&gt;
   &lt;td style="text-align:center;background-color: Linen !important;"&gt; Trachea, Bronchus and Lung &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:center;background-color: white !important;"&gt; Colon, Rectosigmoid Junction, Rectum, Anus and Anal Canal &lt;/td&gt;
   &lt;td style="text-align:center;background-color: white !important;"&gt; 84599 &lt;/td&gt;
   &lt;td style="text-align:center;background-color: white !important;"&gt; 84502 &lt;/td&gt;
   &lt;td style="text-align:center;background-color: white !important;"&gt; Colon, Rectosigmoid Junction, Rectum, Anus and Anal Canal &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:center;background-color: Linen !important;"&gt; Pancreas &lt;/td&gt;
   &lt;td style="text-align:center;background-color: Linen !important;"&gt; 48418 &lt;/td&gt;
   &lt;td style="text-align:center;background-color: Linen !important;"&gt; 54717 &lt;/td&gt;
   &lt;td style="text-align:center;background-color: Linen !important;"&gt; Pancreas &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:center;background-color: white !important;"&gt; Ovary &lt;/td&gt;
   &lt;td style="text-align:center;background-color: white !important;"&gt; 36724 &lt;/td&gt;
   &lt;td style="text-align:center;background-color: white !important;"&gt; 36253 &lt;/td&gt;
   &lt;td style="text-align:center;background-color: white !important;"&gt; Ovary &lt;/td&gt;
  &lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;


 * **Same cancers** as the top 5 for both years
 
 * **Increases:** Breast, Trachea/Bronchus/Lung and Pancreas
 
 * **Decreases:** Colon and Ovary
 
---
class: ninth-slide, middle

.center[
## Most common cancers for Males in 2011 and 2016
]






&lt;table class="table table-striped" style="margin-left: auto; margin-right: auto;"&gt;
 &lt;thead&gt;
&lt;tr&gt;
&lt;th style="border-bottom:hidden; padding-bottom:0; padding-left:3px;padding-right:3px;text-align: center; padding-right: 4px; padding-left: 4px; background-color: white !important;" colspan="2"&gt;&lt;div style="border-bottom: 1px solid #ddd; padding-bottom: 5px; "&gt;2011&lt;/div&gt;&lt;/th&gt;
&lt;th style="border-bottom:hidden; padding-bottom:0; padding-left:3px;padding-right:3px;text-align: center; padding-right: 4px; padding-left: 4px; background-color: white !important;" colspan="2"&gt;&lt;div style="border-bottom: 1px solid #ddd; padding-bottom: 5px; "&gt;2016&lt;/div&gt;&lt;/th&gt;
&lt;/tr&gt;
  &lt;tr&gt;
   &lt;th style="text-align:center;background-color: Linen !important;"&gt; CancerSite &lt;/th&gt;
   &lt;th style="text-align:center;background-color: Linen !important;"&gt; Deaths &lt;/th&gt;
   &lt;th style="text-align:center;background-color: Linen !important;"&gt; Deaths &lt;/th&gt;
   &lt;th style="text-align:center;background-color: Linen !important;"&gt; CancerSite &lt;/th&gt;
  &lt;/tr&gt;
 &lt;/thead&gt;
&lt;tbody&gt;
  &lt;tr&gt;
   &lt;td style="text-align:center;background-color: white !important;font-style: italic;"&gt; Trachea, Bronchus and Lung &lt;/td&gt;
   &lt;td style="text-align:center;background-color: white !important;font-style: italic;"&gt; 221683 &lt;/td&gt;
   &lt;td style="text-align:center;background-color: white !important;font-style: italic;"&gt; 219810 &lt;/td&gt;
   &lt;td style="text-align:center;background-color: white !important;font-style: italic;"&gt; Trachea, Bronchus and Lung &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:center;background-color: Linen !important;"&gt; Colon, Rectosigmoid Junction, Rectum, Anus and Anal Canal &lt;/td&gt;
   &lt;td style="text-align:center;background-color: Linen !important;"&gt; 99885 &lt;/td&gt;
   &lt;td style="text-align:center;background-color: Linen !important;"&gt; 103728 &lt;/td&gt;
   &lt;td style="text-align:center;background-color: Linen !important;"&gt; Colon, Rectosigmoid Junction, Rectum, Anus and Anal Canal &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:center;background-color: white !important;"&gt; Prostate &lt;/td&gt;
   &lt;td style="text-align:center;background-color: white !important;"&gt; 89318 &lt;/td&gt;
   &lt;td style="text-align:center;background-color: white !important;"&gt; 94623 &lt;/td&gt;
   &lt;td style="text-align:center;background-color: white !important;"&gt; Prostate &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:center;background-color: Linen !important;"&gt; Pancreas &lt;/td&gt;
   &lt;td style="text-align:center;background-color: Linen !important;"&gt; 48513 &lt;/td&gt;
   &lt;td style="text-align:center;background-color: Linen !important;"&gt; 54834 &lt;/td&gt;
   &lt;td style="text-align:center;background-color: Linen !important;"&gt; Pancreas &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:center;background-color: white !important;font-style: italic;"&gt; Stomach &lt;/td&gt;
   &lt;td style="text-align:center;background-color: white !important;font-style: italic;"&gt; 44264 &lt;/td&gt;
   &lt;td style="text-align:center;background-color: white !important;font-style: italic;"&gt; 42702 &lt;/td&gt;
   &lt;td style="text-align:center;background-color: white !important;font-style: italic;"&gt; Liver and Intrahepatic Bile Ducts &lt;/td&gt;
  &lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;


 * Only change is **Liver over Stomach**
 
 * **Trachea/Bronchus/Lungs** is the **deadliest** by a large margin
 
 * Most **cancers increase** in number of deaths
 
---
class: conclusion-slide, middle

.center[
## Conclusions
]

* Data shows an overall **slight increase in the mortality rate** for Liver and Intrahepatic Bile Ducts cancer (2011 to 2016).
 
* Data also shows that this cancer is **more aggressive to older people**, showing higher mortality rates
 
* **Most common cancers** are (almost) the **same** from 2011 to 2016.
 
* **Lack of data for 2017** makes this analysis more difficult &amp; given the data limitations, the **true mortality rate might be higher**

&lt;img src="ninja-presentation_files/figure-html/ggA2-1.gif" style="display: block; margin: auto;" /&gt;
    </textarea>
<style data-target="print-only">@media screen {.remark-slide-container{display:block;}.remark-slide-scaler{box-shadow:none;}}</style>
<script src="https://remarkjs.com/downloads/remark-latest.min.js"></script>
<script>var slideshow = remark.create({
"slideNumberFormat": "<div class=\"progress-bar-container\">   <div class=\"progress-bar\" style=\"width: calc(%current% / %total% * 100%);\">   </div> </div>` ",
"highlightStyle": "github",
"highlightLines": true,
"countIncrementalSlides": false,
"widescreen": true
});
if (window.HTMLWidgets) slideshow.on('afterShowSlide', function (slide) {
  window.dispatchEvent(new Event('resize'));
});
(function(d) {
  var s = d.createElement("style"), r = d.querySelector(".remark-slide-scaler");
  if (!r) return;
  s.type = "text/css"; s.innerHTML = "@page {size: " + r.style.width + " " + r.style.height +"; }";
  d.head.appendChild(s);
})(document);

(function(d) {
  var el = d.getElementsByClassName("remark-slides-area");
  if (!el) return;
  var slide, slides = slideshow.getSlides(), els = el[0].children;
  for (var i = 1; i < slides.length; i++) {
    slide = slides[i];
    if (slide.properties.continued === "true" || slide.properties.count === "false") {
      els[i - 1].className += ' has-continuation';
    }
  }
  var s = d.createElement("style");
  s.type = "text/css"; s.innerHTML = "@media print { .has-continuation { display: none; } }";
  d.head.appendChild(s);
})(document);
// delete the temporary CSS (for displaying all slides initially) when the user
// starts to view slides
(function() {
  var deleted = false;
  slideshow.on('beforeShowSlide', function(slide) {
    if (deleted) return;
    var sheets = document.styleSheets, node;
    for (var i = 0; i < sheets.length; i++) {
      node = sheets[i].ownerNode;
      if (node.dataset["target"] !== "print-only") continue;
      node.parentNode.removeChild(node);
    }
    deleted = true;
  });
})();
// adds .remark-code-has-line-highlighted class to <pre> parent elements
// of code chunks containing highlighted lines with class .remark-code-line-highlighted
(function(d) {
  const hlines = d.querySelectorAll('.remark-code-line-highlighted');
  const preParents = [];
  const findPreParent = function(line, p = 0) {
    if (p > 1) return null; // traverse up no further than grandparent
    const el = line.parentElement;
    return el.tagName === "PRE" ? el : findPreParent(el, ++p);
  };

  for (let line of hlines) {
    let pre = findPreParent(line);
    if (pre && !preParents.includes(pre)) preParents.push(pre);
  }
  preParents.forEach(p => p.classList.add("remark-code-has-line-highlighted"));
})(document);</script>

<script>
(function() {
  var links = document.getElementsByTagName('a');
  for (var i = 0; i < links.length; i++) {
    if (/^(https?:)?\/\//.test(links[i].getAttribute('href'))) {
      links[i].target = '_blank';
    }
  }
})();
</script>

<script>
slideshow._releaseMath = function(el) {
  var i, text, code, codes = el.getElementsByTagName('code');
  for (i = 0; i < codes.length;) {
    code = codes[i];
    if (code.parentNode.tagName !== 'PRE' && code.childElementCount === 0) {
      text = code.textContent;
      if (/^\\\((.|\s)+\\\)$/.test(text) || /^\\\[(.|\s)+\\\]$/.test(text) ||
          /^\$\$(.|\s)+\$\$$/.test(text) ||
          /^\\begin\{([^}]+)\}(.|\s)+\\end\{[^}]+\}$/.test(text)) {
        code.outerHTML = code.innerHTML;  // remove <code></code>
        continue;
      }
    }
    i++;
  }
};
slideshow._releaseMath(document);
</script>
<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
(function () {
  var script = document.createElement('script');
  script.type = 'text/javascript';
  script.src  = 'https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-MML-AM_CHTML';
  if (location.protocol !== 'file:' && /^https?:/.test(script.src))
    script.src  = script.src.replace(/^https?:/, '');
  document.getElementsByTagName('head')[0].appendChild(script);
})();
</script>
  </body>
</html>
